Pacific Biosciences of California, Inc. (NASDAQ: PACB)
$2.0900
-0.0100 ( +2.96% ) 13.3M
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.
Market Data
Open
$2.0900
Previous close
$2.1000
Volume
13.3M
Market cap
$618.06M
Day range
$1.9760 - $2.2050
52 week range
$1.1600 - $8.4800
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k/a | 8K-related | 15 | Dec 13, 2024 |
8-k | 8K-related | 13 | Dec 13, 2024 |
8-k | 8K-related | 13 | Dec 06, 2024 |
8-k | 8K-related | 43 | Nov 22, 2024 |
8-k | 8K-related | 13 | Nov 12, 2024 |
10-q | Quarterly Reports | 79 | Nov 12, 2024 |
8-k | 8K-related | 14 | Nov 07, 2024 |
8-k | 8K-related | 15 | Nov 07, 2024 |
4 | Insider transactions | 1 | Oct 02, 2024 |
4 | Insider transactions | 1 | Sep 17, 2024 |